BTAI- Bioxcel Therapeutics, Inc.

Name: Bioxcel Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Bioxcel Therapeutics, Inc. (BTAI) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. BTAI is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Miller Michael Patrick	17.0K	$20.2K	-
Dir	Mack David J.	17.0K	$20.2K	-
Dir	Laumas Sandeep	17.0K	$20.2K	-
Dir	Patni Rajiv	17.0K	$20.2K	-
Dir	Votruba Michal	17.0K	$20.2K	-

Activity

Buys and sells only

Transactions

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 20, 2023	O'Neill Vincent86	Chief Medical Officer	Sale+OE	29,713	$30.00	$891,390.00	-100%	-30.2%	-91.5%
Jan 5, 2023	Nandabalan Krishnan75	Director, 10% Owner	Sale+OE	60,000	$22.01	$1,320,875.99	-85.0%	-23.3%	-87.4%
Dec 16, 2022	Mehta Vimal92	CEO And President	Sale+OE	60,000	$19.69	$1,181,497.75	-51.3%	-3.0%	-83.8%
Nov 11, 2022	Nandabalan Krishnan75	Director, 10% Owner	Sale+OE	60,000	$15.00	$900,000.00	-100%	+104.4%	-67.3%
Jun 25, 2021	Mehta Vimal92	CEO, President And Secretary	Sell	473,250	$30.83	$14,589,492.98	-5.2%	+3.1%	-61.0%
Jun 25, 2021	Bioxcel Holdings, Inc.	10% Owner	Sell	473,250	$30.83	$14,589,492.98	-5.2%	+3.1%	-61.0%
Jun 25, 2021	Bioxcel LLC	10% Owner	Sell	473,250	$30.83	$14,589,492.98	-5.2%	+3.1%	-61.0%
Jun 25, 2021	Nandabalan Krishnan75	Director	Sell	473,250	$30.83	$14,589,492.98	-5.2%	+3.1%	-61.0%
Mar 15, 2021	Yocca Frank88	Chief Scientific Officer	Sell	15,000	$48.50	$727,572.90	-11.3%	-21.2%	-69.1%
Feb 17, 2021	O'Neill Vincent86	Chief Medical Officer	Sale+OE	25,000	$55.58	$1,389,459.15	-33.1%	-	-

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC